In addition to the effects of aging populations and increasing obesity rates, some studies have suggested that the increased prevalence of prostate cancer in the Chinese population might also be due to the wider implementation of improved, more sensitive prostate cancer screening in recent decades including the screening for serum prostate-specific antigen (PSA) (7). The gene discussed is KLK3; the disease is obesity disorder.